Successful pregnancy after Intralipid addition to sildenafil and enoxaparin in woman with history of recurrent pregnancy loss (RPL).
OBJECTIVE
Does addition of Intralipid to sildenafil and enoxaparin immunotherapy improve pregnancy outcome?


METHODS
Report of a striking case of a patient with history of 4 recurrent pregnancy losses (RPL) and IVF failures.


RESULTS
Adding of Intralipid resulted in giving birth to a healthy male baby in the 3th IVF cycle.


CONCLUSIONS
Combination therapy that includes Intralipid may generate successful IVF outcome, although this problem merits further study, especially regarding safety issues.
Department of Gynecology and Oncological Gynecology, Military Institute of Medicine, Warsaw, Poland.
Malgorzata
M
Jerzak
Department of Gynecology and Oncological Gynecology, Military Institute of Medicine, Warsaw, Poland.
Monika
M
Szafarowska
Department of Clinical Immunology, Transplantation Institute, University Medical School, Warsaw, Poland.
Monika
M
Kniotek
Department of Clinical Immunology, Transplantation Institute, University Medical School, Warsaw, Poland.
Andrzej
A
Gorski
D000026:Abortion, Habitual / Q000628:therapy*; D000328:Adult; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011256:Pregnancy Outcome; D000068677:Sildenafil Citrate / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D017984:Enoxaparin; D000068677:Sildenafil Citrate